We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAT icon
951
Caterpillar
CAT
$402B
– –
-3,171
Closed -$1.06M
CBRE icon
952
CBRE Group
CBRE
$42.1B
– –
-6,144
Closed -$547K
CBZ icon
953
CBIZ
CBZ
$2.39B
– –
-2,862
Closed -$212K
CCI icon
954
Crown Castle
CCI
$32.4B
– –
-15,878
Closed -$1.55M
CCL icon
955
Carnival Corporation Ltd
CCL
$37.1B
– –
-26,911
Closed -$504K
CELH icon
956
Celsius Holdings
CELH
$7.36B
– –
-34,318
Closed -$1.96M
CHD icon
957
Church & Dwight Co
CHD
$23.4B
– –
-4,576
Closed -$474K
CHE icon
958
Chemed
CHE
$6.76B
– –
-2,041
Closed -$1.11M
CHWY icon
959
Chewy
CHWY
$8.93B
– –
-12,878
Closed -$351K
CLBT icon
960
Cellebrite
CLBT
$3.65B
– –
-11,112
Closed -$133K
CME icon
961
CME Group
CME
$91.8B
– –
-12,722
Closed -$2.5M
CMS icon
962
CMS Energy
CMS
$22.9B
– –
-25,232
Closed -$1.5M
CNC icon
963
Centene
CNC
$31.6B
– –
-4,622
Closed -$306K
COUR icon
964
Coursera
COUR
$1.61B
– –
-38,383
Closed -$275K
CRH icon
965
CRH
CRH
$68.7B
– –
-23,093
Closed -$1.73M
CRVL icon
966
CorVel
CRVL
$3.08B
– –
-7,773
Closed -$659K
CSCO icon
967
Cisco
CSCO
$452B
– –
-15,007
Closed -$713K
CSIQ icon
968
Canadian Solar
CSIQ
$936M
– –
-39,096
Closed -$577K
CSW
969
CSW Industrials
CSW
$4.78B
– –
-6,589
Closed -$1.75M
CUBE icon
970
CubeSmart
CUBE
$9.57B
– –
-7,842
Closed -$354K
CVE icon
971
Cenovus Energy
CVE
$52.3B
– –
-12,332
Closed -$242K
CWEN icon
972
Clearway Energy Class C
CWEN
$5B
– –
-24,269
Closed -$599K
CWH icon
973
Camping World
CWH
$389M
– –
-27,657
Closed -$494K
CXM icon
974
Sprinklr
CXM
$1.42B
– –
-12,044
Closed -$116K
CYH icon
975
Community Health Systems
CYH
$383M
– –
-32,808
Closed -$110K
37 38
39
40 41

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.